The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Mariano Valdes
Showing 1-4 of 4 articles
A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)
Garcia-Touchard A,
Goicolea J,
Sabaté M,
Alfonso F,
Ruiz-Salmeron R,
Bethencourt A,
Gonzalo N,
Miranda F,
García del Blanco B,
Jimenez Mazuecos J,
Melgares R,
Martinez-Romero P,
Hernandez-Garcia J,
Lezaun R,
Bullones J,
Fernandez Portales J,
Rumoroso J-R,
Ortas R,
Valdes M,
Trillo R,
Brugaletta S,
Otzuki S,
Hernández Pérez FJ,
Alonso-Pulpón L
January 20, 2017 | 10.4244/EIJ-D-16-00128
Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial
Fajadet J,
Neumann F,
Hildick-Smith D,
Petronio A,
Zaman A,
Spence M,
Wöhrle J,
Elhadad S,
Roberts D,
Hovasse T,
Valdes M,
Silber S
January 20, 2017 | 10.4244/EIJV12I13A262
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
Vlachojannis G,
Smits P,
Hofma S,
Togni M,
Vázquez N,
Valdes M,
Voudris V,
Puricel S,
Slagboom T,
Goy J-J,
den Heijer P,
van der Ent M
July 20, 2015 | 10.4244/EIJV11I3A53
A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial
Moreno R,
Garcia E,
Teles R,
Almeida M,
Carvalho H,
Sabaté M,
Martin-Reyes R,
Rumoroso J-R,
Galeote G,
Goicolea F,
Moreu J,
Mainar V,
Mauri J,
Ferreira R,
Valdes M,
Perez de Prado A,
Martin-Yuste V,
Jiménez-Valero S,
Sanchez Recalde A,
Calvo L,
de Sa E,
Macaya C,
López-Sendón J-L
May 25, 2010
1
Latest news
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke